Evidence map›Paper›PMID 39076244›Full record

ReviewReviews in cardiovascular medicine2022

Cardiac manifestations in hyperthyroidism.

Alberto Navarro-Navajas, José David Cruz, Nicolas Ariza-Ordoñez, Helman Giral, Jorge Palmezano, Adrián Bolívar-Mejía, Quindo Santana, Ricardo Fernandez, Luisa Durango, Clara Saldarriaga and 5 more

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alberto Navarro-NavajasEscuela de medicina, Universidad del Bosque, Fundación Cardioinfantil, 110131 Bogota, Colombia.
José David CruzEscuela de medicina y ciencias de la salud, Universidad del Rosario, Fundación Cardioinfantil, 110131 Bogota, Colombia.
Nicolas Ariza-OrdoñezEscuela de medicina y ciencias de la salud, Universidad del Rosario, Fundación Cardioinfantil, 110131 Bogota, Colombia.
Helman GiralEscuela de medicina y ciencias de la salud, Universidad del Rosario, Fundación Cardioinfantil, 110131 Bogota, Colombia.
Jorge PalmezanoEscuela de medicina, Universidad Pontificia Bolivariana, Cardio-VID Clinic, 050010 Medellin, Colombia.
Adrián Bolívar-MejíaEscuela de medicina, Universidad Pontificia Bolivariana, Cardio-VID Clinic, 050010 Medellin, Colombia.
Quindo SantanaDepartamento de cardiología, Cardio-VID Clinic, 050010 Medellin, Colombia.
Ricardo FernandezDepartamento de cardiología, Cardio-VID Clinic, 050010 Medellin, Colombia.
Luisa DurangoDepartamento de cardiología, Cardio-VID Clinic, 050010 Medellin, Colombia.
Clara SaldarriagaPrograma de falla cardiaca, Cardio-VID Clinic, 050010 Medellin, Colombia.
Juan Camilo MateusEscuela de medicina y ciencias de la salud, Universidad del Rosario, Fundación Cardioinfantil, 110131 Bogota, Colombia.
Diego GarnicaEscuela de medicina, Universidad del Bosque, Fundación Cardioinfantil, 110131 Bogota, Colombia.
José Guillermo Sarta-GarcíaCentro de Investigación Biomédica Universidad de La Sabana (CIBUS), Fundación Cardioinfantil, 110131 Bogota, Colombia.
Fernando LizcanoCentro de Investigación Biomédica Universidad de La Sabana (CIBUS), Fundación Cardioinfantil, 110131 Bogota, Colombia.
Carlos Andrés TapiasDepartamento de electrofisiología, Centro Internacional de Arritmias, Fundación Cardioinfantil, 110131 Bogota, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid hormones have a fundamental impact on cardiac function that is mediated by genomic and nongenomic effects, alterations that condition physiological repercussions that lead to changes in frequency, contractility, rhythm and cardiac output as well as an increase in the incidence and prevalence of different cardiovascular diseases. This document presents an updated review of the implications that hyperthyroidism has in different cardiac conditions, including its importance in the evaluation of perioperative cardiovascular risk.

Indexed as

cardiovascular diseaseheart failurehyperthyroidism

Identifiers

PMID39076244
PMCPMC11273775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.